Detection of severe hypertension in a patient with neurofibromatosis type 1 during anesthesia induction: a case report

[1]  D. Babovic‐Vuksanovic,et al.  Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1 , 2017, Clinical endocrinology.

[2]  W. Young,et al.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline. , 2014, The Journal of clinical endocrinology and metabolism.

[3]  C. Solórzano,et al.  Pheochromocytoma in Neurofibromatosis Type 1: When Should it Be Suspected? , 2014, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[4]  R. Cianci,et al.  Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects , 2011, Archives of Dermatological Research.

[5]  J. Radcliffe,et al.  Neurofibromatosis: clinical presentations and anaesthetic implications. , 2001, British journal of anaesthesia.

[6]  W. Linehan,et al.  von Recklinghausen's disease and pheochromocytomas. , 1999, The Journal of urology.

[7]  B. Korf,et al.  The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. , 1997, JAMA.

[8]  S. Huson.  Recent developments in the diagnosis and management of neurofibromatosis. , 1989, Archives of disease in childhood.